A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model-Reference-Cited by-同舟云学术

A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model

Published:2014-03-12 Issue:3 Volume:9 Page:e91516
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Buttigieg Karen R.,Dowall Stuart D.,Findlay-Wilson Stephen,Miloszewska Aleksandra,Rayner Emma,Hewson Roger,Carroll Miles W.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference67 articles.

1. Chumakov MP (1945) A new tick borne disease – Crimean hemorrhagic fever. In: Sokolov AA, Chumakov MP, Kolachev, editors. Crimean hemorrhagic fever (acute infectious capillary toxicosis). Simferopol: Izd. Otd. Primorskoi Armii. pp. 13–43.

2. Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus;J Casals;Proc Soc Exp Biol Med,1969

3. Management of patients with suspected viral hemorrhagic fever;MMWR Morb Mortal Wkly Rep,1988

4. Crimean-Congo haemorrhagic fever;O Ergonul;Lancet Infect Dis,2006

5. The clinical pathology of Crimean-Congo hemorrhagic fever;R Swanepoel;Rev Infect Dis,1989

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

2. Purification and characterization of soluble recombinant Crimean-Congo hemorrhagic fever virus glycoprotein Gc expressed in mammalian 293F cells;BMC Biotechnology;2024-08-27

3. Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model;Virus Research;2024-08

4. Recent Advances in Crimean-Congo Hemorrhagic Fever Virus Detection, Treatment, and Vaccination: Overview of Current Status and Challenges;Biological Procedures Online;2024-06-26

5. Vaccine Development;Pediatric Clinics of North America;2024-06